Abrdn PLC Geron Corp Transaction History
Abrdn PLC
- $57.3 Billion
- Q2 2025
A detailed history of Abrdn PLC transactions in Geron Corp stock. As of the latest transaction made, Abrdn PLC holds 6,985,932 shares of GERN stock, worth $9.08 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
6,985,932
Previous 3,692,753
89.18%
Holding current value
$9.08 Million
Previous $5.87 Million
67.77%
% of portfolio
0.02%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding GERN
# of Institutions
299Shares Held
500MCall Options Held
799KPut Options Held
463K-
Ra Capital Management, L.P. Boston, MA60.4MShares$78.5 Million1.99% of portfolio
-
Black Rock Inc. New York, NY46.6MShares$60.5 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT38.2MShares$49.6 Million2.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA34.1MShares$44.4 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA27.2MShares$35.4 Million11.75% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $491M
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...